002326:SZSEZhejiang Yongtai Technology Co.,Ltd. Analysis
Data as of 2026-06-13 - not real-time
CN¥21.62
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Zhejiang Yongtai Technology operates in a niche chemicals segment with strong top‑line growth but thin margins and a cash‑heavy balance sheet. The stock trades at an extremely high trailing P/E while the forward P/E compresses to a much lower level, and a discounted cash‑flow model suggests a fair value far below the current market price, indicating serious overvaluation. Technical indicators show a neutral price trend, a modest bullish MACD histogram, and stable volume, yet volatility remains high and recent drawdowns have been sharp.
The company carries a heavy debt load relative to equity, generates modest returns on equity and assets, and faces sector‑specific regulatory scrutiny on fluorinated chemicals and lithium‑related products. Combined with an “Extreme Greed” market sentiment reading, the risk profile leans toward the higher end, suggesting caution for investors.
The company carries a heavy debt load relative to equity, generates modest returns on equity and assets, and faces sector‑specific regulatory scrutiny on fluorinated chemicals and lithium‑related products. Combined with an “Extreme Greed” market sentiment reading, the risk profile leans toward the higher end, suggesting caution for investors.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- stock price far exceeds intrinsic valuation
- high short‑term volatility and recent drawdown
- neutral technical trend with limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential for earnings improvement if margins expand
- forward earnings multiple appears more reasonable
- ongoing regulatory exposure may limit upside
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- fundamental restructuring needed to reduce leverage
- growth in specialty chemicals could eventually support valuation
- persistent low profitability and high debt keep risk elevated
Key Metrics & Analysis
Financial Health
Revenue Growth59.70%
Profit Margin0.82%
P/E Ratio432.4
ROE3.05%
ROA1.30%
Debt/Equity162.90
P/B Ratio7.0
Op. Cash FlowCN¥55.0M
Free Cash FlowCN¥192.7M
Technical Analysis
TrendNeutral
RSI44.4
SupportCN¥20.59
ResistanceCN¥24.84
MA 20CN¥22.19
MA 50CN¥23.29
MA 200CN¥22.32
MACDBullish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair ValueCN¥3.02
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.45
Volatility54.71%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.